SuperworthPACS EPS PACS
Diluted earnings per share by quarter and over the last twelve months, from 2023.
- Last 12 months, to Jun 30, 2026
- $1.75
- Latest quarter, Q2 FY26
- $0.47
- +52% on a year earlier
- Fiscal year 2025
- $1.26
- +215% on the year before
PACS' earnings per share was $1.75 over the twelve months to Jun 30, 2026, up 113% on a year earlier.
In its latest quarter, Q2 FY26, it was $0.47, up 52% on the same quarter a year before.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | $1.26 | +215% |
| FY2024 | $0.40 | −54% |
| FY2023 | $0.87 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | $0.47 | +52% | $1.75 | |
| Q1 FY26 | $0.50 | +194% | $1.59 | |
| Q4 FY25 | $0.46 | +92% | $1.26 | |
| Q3 FY25 | $0.32 | +220% | $1.04 | |
| Q2 FY25 | $0.31 | n/a | $0.82 | |
| Q1 FY25 | $0.17 | −37% | $0.30 | |
| Q4 FY24 | $0.24 | −11% | $0.40 | |
| Q3 FY24 | $0.10 | −33% | $0.43 | |
| Q2 FY24 | −$0.21 | −231% | $0.48 | |
| Q1 FY24 | $0.27 | −7% | $0.85 | |
| Q4 FY23 | $0.27 | n/a | $0.87 | |
| Q3 FY23 | $0.15 | n/a | n/a |
Against its peers
Companies in Medical - Care Facilities nearest PACS' size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| PACSPACS | $1.75 | +113% a year |
| CHEChemed | $19.92 | +2% a year |
| ENSGEnsign | $6.38 | +16% a year |
| UHSUniversal Health Services | $24.55 | +29% a year |
| SHCSotera Health | $0.57 | +613% a year |
| CONConcentra Group Holdings Parent | $1.54 | +29% a year |
| LFSTLifeStance Health | $0.13 | |
| DVADavita | $12.22 | +20% a year |
| BTSGBrightSpring Health Services | $1.65 | +432% a year |
| OPCHOption Care Health | $1.33 | +6% a year |
| EHCEncompass Health | $6.14 | +20% a year |
| Peer median | $3.90 |
Where PACS ranks
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on PACS
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.